Consider writing about:
An Oct. 1st directive issued by the U.S. Department of Justice, “Corporate Enforcement in the Fight Against Fraud;” centrality of health care fraud to the effort described in this memo; what the healthcare industry should note about the “all-tools approach” the DOJ is saying it will take to fighting fraud; how the industry should prepare for the possibility of federal investigations and other pressures or enforcement actions in light of the Oct. 1st DOJ memo; what else to know about the Trump administration’s evolving approach to alleged incidents, or risks, of healthcare fraud.
Related information: